Cash Flow Statement
Growth Metrics

Xtant Medical Holdings (XTNT) EBIT Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.83%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.06%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 19.54%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 20.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 74.18%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 90.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -18.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 46.60%
10 Xtant Medical Holdings 64.46 Mn 47.14 Mn 17.75 Mn 161.97%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 161.97%
Sep 30, 2025 167.28%
Jun 30, 2025 256.96%
Mar 31, 2025 130.63%
Dec 31, 2024 278.06%
Sep 30, 2024 -11.58%
Jun 30, 2024 -111.79%
Mar 31, 2024 -120.18%
Dec 31, 2023 -216.61%
Sep 30, 2023 -78.16%
Jun 30, 2023 -7.00%
Mar 31, 2023 13.93%
Dec 31, 2022 270.80%
Sep 30, 2022 -31.49%
Jun 30, 2022 -164.77%
Mar 31, 2022 -36,520.00%
Dec 31, 2021 -352.84%
Sep 30, 2021 -290.13%
Jun 30, 2021 -26.87%
Mar 31, 2021 99.63%
Dec 31, 2020 -32.70%
Sep 30, 2020 207.80%
Jun 30, 2020 31.26%
Mar 31, 2020 -104.04%
Dec 31, 2019 96.60%
Sep 30, 2019 50.87%
Jun 30, 2019 75.10%
Mar 31, 2019 59.69%
Dec 31, 2018 61.40%
Sep 30, 2018 69.37%
Jun 30, 2018 64.40%
Mar 31, 2018 35.45%
Dec 31, 2017 -1,996.09%
Sep 30, 2017 -146.11%
Jun 30, 2017 -199.23%
Mar 31, 2017 -8.65%
Dec 31, 2016 71.63%
Sep 30, 2016 61.03%
Jun 30, 2016 -53.44%
Mar 31, 2016 -36.36%
Dec 31, 2015 -63.73%
Sep 30, 2015 -290.66%
Jun 30, 2015 -3.85%
Mar 31, 2015 -45.36%
Dec 31, 2014 30.04%
Sep 30, 2014 46.74%
Jun 30, 2014 28.65%
Mar 31, 2014 3.36%
Dec 31, 2013 -0.65%
Sep 30, 2013 -1,203.58%
Jun 30, 2013 -437.48%
Mar 31, 2013 3.12%
Dec 31, 2012 -32.53%
Sep 30, 2012 113.59%
Jun 30, 2012 -24.06%
Mar 31, 2012 34.25%
Dec 31, 2011 33.60%
Sep 30, 2011 24.91%
Jun 30, 2011 78.08%